Characteristic | Patients exposed to intervention (N= 49) | Control group (N=50) | Difference between exposed and control groups | |
---|---|---|---|---|
Gender | Female | 12 | 12 | χ2=0.003, p=0.955 |
Male | 37 | 38 | ||
Age (years), mean±SD (range) | 54.9±9.5 (33–88) | 54.8±11.9 (32–88) | T=0.010, p=0.992 | |
Age categories (years) | 30–40 | 3 | 5 | χ2=7.708, p=0.103 |
41–50 | 8 | 16 | ||
51–60 | 24 | 12 | ||
61–70 | 13 | 13 | ||
71–90 | 1 | 4 | ||
Diagnosis | F20 | 46 | 45 | χ2=6.002, p=0.423 |
F22 | 1 | 1 | ||
F29 | 1 | 1 | ||
F23, F25 F33 | 1 | 3 | ||
Duration of disease (years), mean±SD (range) | 21.5±10.9 (1.0–44.0) | 18.4±10.2 (1.0–45.0) | T=-1.466, p=0.146 | |
Duration of hospitalisation (years), mean±SD (range) | 12.1±9.0 (1.0–42.0) | 10.9±9.7 (1.0–45.0) | T=-0.617, p=0.539 | |
Hospitalisation (number of patients) | Dismissed at weekends | 11 | 13 | χ2=0.170, p=0.680 |
Continuous | 38 | 37 | ||
Number of prescribed drugs per patient, mean±SD (range) | Before the intervention | 4.2±1.5 (2–8) | 4.0±0.9 (2–8) | T=-0.828, p=0.410 |
After the intervention | 3.4±1.6 (0–7) | 3.9±0.9 (2–8) | T=-1.017, p=0.312 | |
Difference before/after | Tpaired=-3.263, p=0.002* | Tpaired=-1.003, p=0.320 |
*Significant difference.